2Lichtenstein DR,Syngal S,Wolfe MM.Nonsteroidal antiinflamatorydrugs and the gastrointestinal tract.The double-edged sword.Arthritis Rheum,1995,38 (1):5-18.
3Howard PA,Delarontaine P.Nonsteroidal anti-Inflamlllatory drugs and cardiovascular risk.J Am Coll Car,2004,43(4) ;519-525.
4Ding C.Do NSAIDs affect the progression of osteoarthritis? Inflammation,2002,26(3):139-142.
5Vane JR,Botting RM.Mechanism of action of nonSteroidal anti-inflammatorydrugS.Am J Med,1998,104 (3A):2-8; discussion 21-22.
6Botting RM.Mechanism of action of acetaminophen:iS there a cyclooxygenase 37.Linical lnfectious diseases,2000 oct,31 Suppl 5:202-210.
7Chandrasekharan NV,Dai H,Roos KL,et al.COX-3,a cyclooxygenase-1 variant inhibited by acctaminophen and Other analgesic/antipyretic drugs:cloning,structure,and expression.Proc Natl Acad SCi U S A,2002,99(21):13926-13931.
8Frolich JC.A classification of of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes.Trends Pharmacol SCi,1997,18 (1):30-34.
9Carson JI,Willett LR.Toxicity of nonsteroidal anti-inflanullatorydrugs.An overview of the epidemiologicol evidence.Drugs,1993,46 Suppl1:243-248.
10Caldwell JR.diclofenac sodium in the treatment of rheumatm oidarthritis and osteoarthritis.Semin ArthritiS Rheum,1985,15(2 Suppl1):73-79.
